NUDT15 C415T变异与TPMT基因分型预测硫唑嘌呤诱导的白细胞减少症的比较:印度1014例炎症性肠病患者的前瞻性分析
该研究基于印度大型炎症性肠病(IBD)注册库的前瞻性数据,比较NUDT15 C415T变异与TPMT基因分型预测硫唑嘌呤诱导白细胞减少症的作用。935例可评估患者中,81例(9%)发生白细胞减少,70例(7.5%)发生中性粒细胞减少;NUDT15 T等位基因与白细胞减少风险升高约19倍(OR 19.35)及中性粒细胞减少风险升高约21倍(OR 21.41)相关。作者认为NUDT15基因分型预测准确性较高,可能有助于优化硫唑嘌呤剂量。
要点
- NUDT15 T等位基因与白细胞减少风险升高相关(OR 19.35,95% CI 11.55-32.42)。
- NUDT15 T等位基因与中性粒细胞减少风险升高相关(OR 21.41,95% CI 12.25-37.41)。
- 白细胞减少患者中仅6.2%为TPMT杂合变异,无纯合变异。
核心结论
- 在印度IBD人群中,NUDT15变异基因分型预测硫唑嘌呤诱导的白细胞减少症比TPMT更准确,可能有助于优化硫唑嘌呤剂量。
研究设计与样本
- 前瞻性收集大型IBD注册库中连续接受硫唑嘌呤治疗患者的数据,分析副作用、停药时间及初始和最大耐受剂量。
- 对NUDT15 C415T(rs116855232;p.R139C)进行基因分型,从生物样本库取血样采用实时聚合酶链反应检测,并与年龄性别匹配的健康志愿者比较。
- 评估NUDT15 C415T与白细胞减少(<3×10^9/L)和中性粒细胞减少(<1.5×10^9/L)的关联;对发生白细胞减少的患者进行TPMT基因分型。
- 共纳入1014例患者(平均年龄35.84±12.74岁;61%男性;54%溃疡性结肠炎,44%克罗恩病,2%IBD未分型),79例因血样不足被排除,剩余935例进行分析。
主要发现
- 935例中81例(9%)发生白细胞减少,70例(7.5%)发生中性粒细胞减少。
- NUDT15 T等位基因(杂合CT和纯合TT vs 野生型CC)与白细胞减少风险升高相关(OR 19.35,95% CI 11.55-32.42;P<0.0001),与中性粒细胞减少风险升高相关(OR 21.41,95% CI 12.25-37.41)。
- CC、CT和TT基因型的中位耐受剂量分别为1.35、1.38和0.92 mg/kg体重(P=0.037);中位治疗持续时间CC、CT、TT分别为18、15和10个月(P=0.003)。
- NUDT15基因型是白细胞减少的独立危险因素(与CC相比,CT HR 11.31,95% CI 6.85-18.03,P<0.0001;TT HR 31.283,95% CI 14.76-66.30)和中性粒细胞减少的独立危险因素(与CC相比,CT HR 13.04,95% CI 7.65-22.22,P<0.0001;TT HR 43.39,95% CI 20.21-92.68)。
- 基于加性预测模型,突变NUDT15等位基因数目预测白细胞减少和中性粒细胞减少的敏感性分别为66.67%和70%,受试者工作特征曲线下面积分别为0.791和0.807;白细胞减少患者中仅6.2%为TPMT杂合变异,无纯合变异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recent studies reported that Nudix Hydrolase 15(NUDT 15) gene variant (C415T) can better predict thiopurine induced leucopenia in Asian patients with inflammatory bowel disease (IBD) than thiopurine S-methyl transferase (TPMT). AIM: To evaluate the role of the NUDT variant compared with TPMT in predicting azathioprine induced leucopenia in Indian IBD patients. METHODS: Prospectively collected data of consecutive patients treated with azathioprine from a large IBD registry were analysed for side effects, discontinuation time, and initial and maximum dose tolerated. Genotyping of NUDT15 C415T (rs116855232; p.R139C) was carried out retrieving blood samples from bio-repository employing real time polymerase chain reaction with age and sex-matched healthy volunteers. The association of NUDT15 C415T with leucopenia (<3 × 109 /L) and neutropenia (<1.5 × 109 /L) was evaluated. TPMT genotyping was done in patients who developed leucopenia. RESULTS: Among 1014 patients (mean age 35.84 ± 12.74 years; 61% males; 54% ulcerative colitis, 44% Crohn's disease and 2% IBD-unclassified), 79 were excluded due to inadequate blood samples. Of the remaining 935, 81 (9%) developed leucopenia and 70 (7.5%) developed neutropenia. The variant "T" allele [heterozygous (CT) and homozygous (TT) versus wild type (CC)] was associated with a 19-fold higher odds (OR19.35, 95% CI11.55-32.42; P < 0.0001) of leucopenia and 21-fold higher odds of neutropenia (OR21.41, 95% CI12.25-37.41). There was significant difference in median dose tolerated between CC, CT and TT (1.35, 1.38 and 0.92 mg/kg body weight, respectively) (P = 0.037) and median duration of therapy (18, 15 and 10 months for CC/CT/TT) (P = 0.003). NUDT15 genotype was an independent risk factor for leucopenia (hazard ratio (HR): CT 11.31, 95% CI6.85-18.03, P < 0.0001 and TT 31.283, 95% CI14.76-66.30 compared to CC) and neutropenia (HR: CT 13.04, 95% CI7.65-22.22, P < 0.0001 and TT 43.39, 95% CI20.21-92.68 compared to CC). The sensitivities for predicting leucopenia and neutropenia by number of mutant NUDT 15 alleles based on additive predictive model were 66.67% and 70% with a receptor operator characteristic curve area under curve value of 0.791 and 0.807, respectively. Among patients with leucopenia, only 6.2% were heterozygous and none were homozygous for TPMT variants. CONCLUSION: NUDT15 variant genotyping appears to be a better predictor for azathioprine-induced leucopenia in an Indian population than TPMT with high accuracy and can be useful in optimizing azathioprine dosage.
引用
- Banerjee R, Ravikanth VV, Pal P, et al. NUDT15 C415T variant compared with TPMT genotyping in predicting azathioprine-induced leucopenia: prospective analysis of 1014 inflammatory bowel disease patients in India. Aliment Pharmacol Ther. 2020. PMID: 33111378. doi:10.1111/apt.16137
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。